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Abstracts / Osteoarthritis and Cartilage 22 (2014) S7–S56 S51Results: 1383 (70.9% females) persons were enrolled in this study.
Mean age, height and weight was 64 years (SD 8.7), 1.66m (SD 0.09)
and 95.12 kg (SD  17.2) respectively. The mean body mass index (BMI)
was 34.4 (SD  5.2) with 81.7% of participants being obese at baseline.
Themean KOOS pain and function scores were 56.3 (SD 16.8) and 59.5
(SD  18.3) respectively at baseline.
1303 (94.2%) of participants had a >2.5% reduction in body weight.
The number (%) of participants according to percentage weight loss
categories were as follows:less than 2.5% ¼79 (5.7%); 2.6-5%¼223
(16.1%), 5.1-7.5% ¼332 (24.0%); 7.6-10% ¼ 317 (22.9%) and >10% ¼
431(31.2%). Participants in weight loss categories did not differ on
gender, age or baseline KOOS measures. There was a signiﬁcant dose-
response relationship to percentage of weight change across all
weight change categories. The dose-response relationship was seen
in all KOOS scores assessed, namely pain, function, symptoms, sport
and recreation and quality of life scores on regression analysis. The
group with the largest amount of weight loss (10%) showed the
most improvement in the pain, function and all the other charac-
teristics assessed (Table 1). The non-weight loss interventions (eg.
strength / balance / mobility exercise, personal support, pain man-
agement strategies etc.) were consistent across the cohort and would
have also contributed to the improvement seen in the low weight
loss group
Conclusions: There is a strong dose response relationship between the
percentage weight loss and the improvement in knee pain, function,
symptoms, sport/recreation and quality of life. The approximately 40%
improvement in symptoms in those losing 10% of their body weight is
consistent with the recent pivotal IDEA trial. This study conﬁrms the
dose-response beneﬁt of weight loss as a therapeutic intervention in
knee osteoarthritis and demonstrates the effectiveness of disseminat-
ing and implementing a weight loss intervention in a community based
setting
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Purpose: To determine whether land-based therapeutic exercise is
beneﬁcial for people with hip OA in terms of reduced joint pain and
improved physical function or quality of life.
Methods: A systematic review and meta-analysis. Five databases were
searched from inception up until February 2013. All randomised con-
trolled trials (RCTs) recruiting people with hip OA and comparing some
form of land-based therapeutic exercise (as opposed to exercises con-
ducted in the water) with a non-exercise group were included. Pro-
grammes could be designed and supervised by physiotherapists or
other professionals, or provided as a home program with minimal
monitoring. Pre-surgery (total hip replacement) programs were exclu-
ded. The comparator could be active (any non-exercise intervention) or
placebo (no treatment or waiting list) group. Studies that compared one
type of exercise programme to another exercise programme, provided
an exercise programme to all treatment allocations (and evaluated the
added beneﬁt of an electrophysical agent or hydrotherapy), compared
exercise with manual therapy and those comparing programmes of
varying intensities, were excluded.
Four reviewers independently selected studies for inclusion. Disagree-
ments were resolved through consensus. Two reviewers independently
extracted data and assessed methodological quality. All analyses were
conducted on continuous outcomes. Results were pooled using stand-
ardised mean differences (SMD) to calculate treatment effect sizes from
the end of treatment scores and related standard deviation (SD) scores,
where possible. Outcomes pooled using SMD were re-expressed as
absolute mean difference using a representative control group (high
weighting in pooled analyses) baseline SD.
Results: A total of ten RCTs were identiﬁed, seven considered to dem-
onstrate a low risk of bias. One of the ten RCTs was only reported as a
conference abstract and did not provide sufﬁcient data for the evalua-
tion of bias risk.
High quality evidence from nine trials (549 participants) indicated
exercise reduces pain (SMD -0.38, 95% CI -0.20 to-0.55) and improves
physical function (SMD -0.38, 95% CI -0.05 to -0.54) immediately aftertreatment. Pain and physical function was estimated to be 40 points on
a 0 to 100 point scale (0 is no pain or loss of physical function) in the
control group; exercise reduced pain by an equivalent of 8 points (4 to
11 points) and improved physical function by an equivalent to 7 points
(1 to 12 points).
The reduction in pain was sustained at least three to six months after
ceasing monitored treatment (ﬁve RCTs, 391 participants): pain (SMD
-0.38, 95% CI -0.18 to -0.58). This translates to a sustained reduction in
pain intensity of 8 points (4 to 12 points) compared to the control group
(0 to 100 scale). The improvement in physical function was also sus-
tained (ﬁve RCTs, 367 participants): physical function (SMD -0.37, 95%
CI -0.16 to -0.57) which translates to a mean improvement of 7 (4 to 13)
points compared to the control group.
There was limited evidence from three studies (183 participants) of no
beneﬁt of exercise in terms of quality of life (SMD -0.10, 95% CI 0.19 to
-0.40).
Only ﬁve of the ten RCTs exclusively recruited people with symptomatic
hip OA (419 participants). There was no signiﬁcant difference in pain or
physical function outcomes compared with ﬁve studies recruiting par-
ticipants with hip or knee OA (130 participants).
Conclusions: Pooling the results of these nine RCTs demonstrated
that land-based therapeutic exercise programs can reduce pain and
improve physical function among people with symptomatic hip
osteoarthritis.
78
EXERCISE THERAPY, MANUAL THERAPY, OR BOTH, FOR
MANAGEMENT OF OSTEOARTHRITIS OF THE HIP OR KNEE: 2-YEAR
FOLLOW-UP OF A RANDOMIZED CLINICAL TRIAL
J.H. Abbott y, C. Chapple y, D. Pinto z, A.A. Wright x, S.L. de la Barra y,
G.D. Baxter y, J.-C. Theis y, f. the MOA Trial Team y. yUniv. of Otago,
Dunedin, New Zealand; zNorthwestern Univ., Chicago, IL, USA; xHigh
Point Univ., High Point, NC, USA
Purpose: There is evidence supporting the effectiveness of both
exercise therapy and manual therapy for hip and knee osteoarthritis
(OA), but few clinical trials report their incremental effectiveness
compared with usual medical care, and most report only short-term
follow-up.
Methods: This was a randomized controlled trial with 2-year follow-up.
Adults meeting the American College of Rheumatology criteria for hip
or knee OA were randomly allocated to receive the following inter-
ventions in addition to usual care: a] exercise therapy; b] manual
therapy; c] combined exercise therapy and manual therapy; or d] no
trial intervention (i.e. usual medical care only). Groups a-c were pro-
vided 10 treatment sessions, including 7 sessions in the ﬁrst 9 weeks,
plus 2 booster sessions at 4 months and 1 at 13 months. Participants
were reassessed at 2 years, blind to group allocation. We report treat-
ment effects on the Western Ontario and McMaster (WOMAC) osteo-
arthritis index (24 questions, 0-10 scale, total range 0-240), quality-
adjusted life years, and physical performance measures (timed up-and-
go, 40m fast-paced walk, 30 second sit-to-stand).
Results: Of 206 participants recruited, 186 (90.3%) were retained at 2
years follow-up. Mean age at baseline was 66 years (range 37 to 92), and
mean WOMAC was 100.8 (SD 53.8). Missing data were replaced using
multiple imputation. Intention-to-treat analysis of covariance
(ANCOVA) showed WOMAC score changes at 2 years were superior for
all three intervention groups compared with the usual care group (2-
sided p<0.05). Participants receiving exercise therapy in addition to
usual care showed gains of 31.7 WOMAC points (95% CI 10.0, 53.3), for
an effect size of 0.57 (Cohen’s d; 95% CI.17, .97). Gains for participants
receiving manual therapy were 30.1 (8.9, 51.3) for an effect size of 0.55
(.16, .94). Gains for participants receiving combined exercise therapy
and manual therapy in addition to usual care did not meet our a priori
threshold for clinical signiﬁcance, at 26.2 (6.1, 46.3) WOMAC points, but
did result in a clinically signiﬁcant effect size of 0.52 (.11, .91). Exercise
therapy in addition to usual care resulted in signiﬁcant QALY gains
comparedwith usual care only (.05 QALYs, p¼.002), but manual therapy
or combined therapy did not (both p>.05). The exercise therapy group
showed greater mean changes on most physical performance tests than
did the other groups.
Conclusions: Both exercise physiotherapy and manual physiotherapy
provided incremental beneﬁt over usual care alone at 2 years follow-up.
QALY gains and physical performance test outcomes signiﬁcantly fav-
oured the exercise therapy group.
